BioSpace News Archive

The medical device additive manufacturing market is expected to reach US$ 4,440.5 million by 2027 from US$ 1,350.4 million in 2019; it is estimated to grow at a CAGR of 16.2% from 2020 to 2027.

The mHealth market was valued at US$ 22,722.1 million in 2017 and it is projected to reach US$ 246,820.4 million in 2025; it is expected to grow at a CAGR of 31.3% from 2016 to 2025.

The sleep apnea devices market was valued at US$ 4,033.0 million in 2016 and it is projected to reach US$ 8,305.3 million in 2025; it is expected to grow at a CAGR of 7.9% from 2016 to 2025.

The Thrombectomy Devices market was valued at US$ 1,282.07 million in 2018 and it is projected to reach US$ 2,101.29 million by 2027; it is expected to grow at a CAGR of 5.9% from 2019 to 2027.

The complex molecule extracted from genes of living organisms by utilizing advanced DNA technologies is collectively known as biologics.

Too many Canadians are struggling to access the drugs they need, especially if they have a rare condition. Work continues on the national strategy to support Canadians who rely on these drugs.

Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced that it has appointed Dr. Tanisha Carino to its Board of Directors.

Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced that it plans to release its second quarter earnings results after market close on Monday, August 9, 2021.

Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today reported financial results for the three months ended June 30, 2021 and provided a corporate update.

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference call at 8:30 a.m. ET on Thursday, August 5, 2021, to discuss its second quarter 2021 financial results and provide a business update.